|
|
7475 Lusk Blvd San Diego, CA 92121 USA phone:800-475-9131 fax:800-475-9134
|
|
| Symbol |
NUVA |
| Exchange |
NASDAQ |
| Founded |
1997 |
| Employees |
105 |
|
|
| www.nuvasive.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Surgical treatment of spine disorders |
 |
| Management |
| Alexis V. Lukianov, Chairman of the Board and Chief Executive Officer; Keith C. Valentine, President & Chief Operating Officer; Michael J. Lambert, Executive Vice President and Chief Financial Officer; Patrick Miles, President of the Americas; Jason M. Hannon, Executive Vice President & General Counsel |
| |
|
|
|
|
|
|
|
| Keywords |
| hydroxyapatite, cervical, intervertebral, electromyography, neurological |
|
|
|
| Description |
|
NuVasive is a medical device company focused on the design, development, and marketing of products for the surgical treatment of spine disorders. The company's product portfolio is focused on applications in the > $4.6 billion U.S. spine fusion market. The company�s current principal product offering includes a minimally disruptive surgical platform called Maximum Access Surgery (MAS), a revolutionary nerve avoidance monitoring system (NeuroVision), an innovative solution to a safe and reproducible lateral access surgery (XLIF), as well as a growing offering of biologics, cervical and motion preservation products. |
 |
| Products / Services |
NuVasive's principal product offerings include a surgical platform called Maximum Access Surgery (MAS) and classic fusion products. MAS combines NeuroVision, a nerve avoidance system, MaXcess, a unique split-blade design retraction system, and specialized implants such as CoRoent and SpheRx Pedicle Screw System. NuVasive's classic fusion portfolio is comprised predominantly of proprietary saline-packaged bone allografts, metal mesh cages and fusion plates. The company began commercializing its products in 2001.
|
 |
| Technology / Differentiation |
| The MAS platform offers advantages for both patients and surgeons, including reduced surgery and hospitalization time and faster recovery. MAS products are designed to collectively minimize soft tissue disruption during spine surgery, while allowing maximum visualization and surgical reproducibility. |
 |
 |
|
|
|
|
|
|